Recent Publications:
Dubois R, M Lauer, EM Perfetto. 2013. When is Evidence Sufficient for Decision Making? – A Framework for Understanding the Pace of Evidence Adoption and Application. Journal of Comparative Effectiveness Research. 2(4), 383–391.
Perfetto EM. July 26, 2013. OPINION: It’s time for NFL to step up on concussions. Cincinnatti Enquirer.
Perfetto EM, J Bailey, B Barefoot, et al. 2012. Communication about results of comparative effectiveness studies: a pharmaceutical industry view. Health Affairs 31(10): 2213-2219.
Subedi P, EM Perfetto, R Ali. 2011. Something old, something new, something borrowed…comparative effectiveness research: a policy perspective. J Manag Care Pharm Nov-Dec;17(9 Suppl A):S05-9.
Recent Presentations:
R Dubois, M Lauer, Perfetto EM. 2013 (July). When is Evidence Sufficient for Decision Making? A Framework for Understanding the Pace of Evidence Adoption. National Pharmacuetical Council Webinar, “When Is the Evidence “Enough” to Make a Health Care Decision?”.
Perfetto EM, M Marquez, and C Bens. 2013 (May). Rules of Engagement: Activating the Patient Voice. Invited Issue Panel. 18th Annual ISPOR International Meeting, New Orleans, LA.
Perfetto EM. 2012 (November). Asymmetry in Medical Communication – The Devil Is In The Detail. Annual Fall Conference, American Society of Medical Association Counsels. Wailea, Hawaii.
Dubois R, D Krakov, T Troy, EM Perfetto. 2012 (November). Discussion Panel: Communicating CER Information: The Dueling Goals of Public health and Commercial Speech. The National Comparative Effectiveness Summit. Washington, DC.
Perfetto, E.M., J. Bailey, B. Barefoot, et al. 2012 (October). Clear Standards and FDA Guidance Could Enable Balanced Communication of CER Results. Health Affairs Briefing. Washington, DC.
Castle, G., Perfetto E.M., Rawlins M., and Frueh F. 2012 (June). Discussion Panel: If you build it, Will they come? The challenge of ensuring payer coverage and payment for new products. The Biopharmaceutical Conference in Europe. Cannes, France.
Schwartz S, MV. Pauly, EM Perfetto, et al. 2012 (June). The Cost Effectiveness of Cost Effectiveness Analysis in Comparative Effectiveness Research: When is Conduct of CEA in Conjunction With CER Required? ISPOR 17th Annual International Meeting Panel.
Bergquist H, JA Doshi, L Fleisher, HA Glick, B Kinosian, S McElligott, EM Perfetto, et al. 2012 (June). The Cost-Effectiveness of Cost-Effectiveness Analysis in Comparative Effectiveness Research. Academy Health Annual Research Meeting. Orlando, Florida.
Gruman J, EM Perfetto, and M McPheeters. 2012 (June). Stakeholder Engagement in Patient-Centered Outcomes Research (PCOR): Can We Make it Meaningful? ISPOR 17th Annual International Meeting Panel. Washington, DC.
Perfetto EM. 2012 (April). Industry Response to CER Expectations. XL Pharma CER Evidence Summit: Counteracting the Impact of Generating Comparative Effectiveness Research Winners and Losers. Washington, DC.
Perfetto EM. 2011 (October), Use of CER by Decision Makers, 2nd Annual Market Access World USA 2011, Washington, DC.
Perfetto EM. 2011 (October), Collaborating with HEOR to Create the Value Message for a Product, 3rd Annual Pharmaceutical Reimbursement and Market Access Event, Philadelphia, PA.
Perfetto EM. 2011 (June), Understand the Application of CER in a Reimbursement Scenario. CBI’s Premier Health Economics and Outcomes Research Congress, Philadelphia, PA.
Perfetto EM. and Kim Caldwell. 2011 (April), Using Comparative Effectiveness Research to Improve the Quality of Care, Academy of Managed Care Pharmacy: 23rd Annual Meeting and Showcase, Minneapolis, MN.
Perfetto EM. 2011 (February). Football, Bran Injury, and CTE: Evidence and Impact. The Santa Clara Brain Injury Conference. Santa Clara, CA.
Perfetto EM. 2010 (June), What Are the Limits of RCTs and Other Clinical Trials for CER? Then What? The Lewin Group Symposium Responding to the National CER Agenda: Evolving Data Sources and Analytics, Washington, DC.
Johnsrud, M, S Sadownik, J Erensen, G Zlateva, EM Perfetto. 2010 (May). Evidence appraisal for the treatment of fibromyalgia: compendia, guidelines, and a review of the literature. ISPOR 16th Annual International Meeting, Atlanta, GA, USA. Abstract published in Value in Health 13(3);133A.
Perfetto EM. 2010 (February), Evolution in Medicare Coverage Mechanisms and CED: The Current CER Agenda and What to Expect in a Post-ARRA CER Agenda. CBI’s 9th Annual Strategic Medicare Policy Summit, Washington, DC.